Insights

Strategic partnership Leverage the recent Merck Animal Health collaboration to position Cambridge Technologies as a trusted autogenous vaccine partner for large poultry programs and explore co-selling or distribution arrangements to expand market reach.

USDA licensed capacity Highlight the 37,000-square-foot USDA-licensed manufacturing facility with advanced fermentation and custom vaccine capabilities to target veterinarians and livestock producers seeking compliant, scalable vaccine solutions.

Custom solutions Emphasize the breadth of customization (adjuvant choices, label options, SoliDose implant delivery) to win RFPs from integrators and multisite operations requiring tailored vaccination strategies.

Emerging disease focus Position Cambridge Technologies as a fast-turnaround partner for emerging animal health problems using metagenomics, sequencing, qPCR, and targeted isolates to deliver timely autogenous vaccines.

Growth and expertise Leverage ongoing hiring of senior scientists and technical staff to reassure prospects about capability depth in diagnostics, R&D, regulatory affairs, and product support for commercial scale deployments.

Similar companies to Cambridge Technologies

Cambridge Technologies Tech Stack

Cambridge Technologies uses 8 technology products and services including Google Ads, HubSpot Analytics, Simpli.fi, and more. Explore Cambridge Technologies's tech stack below.

Media & News

Cambridge Technologies's Email Address Formats

Cambridge Technologies uses at least 2 email formats:
Cambridge Technologies Email FormatsExamplePercentage
FLast@cambridgetechnologies.comJDoe@cambridgetechnologies.com
97%
First@cambridgetechnologies.comJohn@cambridgetechnologies.com
3%

Frequently Asked Questions

What is Cambridge Technologies's official website and social media links?

Minus sign iconPlus sign icon
Cambridge Technologies's official website is cambridgetechnologies.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cambridge Technologies generate?

Minus sign iconPlus sign icon
As of August 2026, Cambridge Technologies's annual revenue is estimated to be $25M - $50M.

What is Cambridge Technologies's SIC code and NAICS code?

Minus sign iconPlus sign icon
Cambridge Technologies's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cambridge Technologies have currently?

Minus sign iconPlus sign icon
As of August 2026, Cambridge Technologies has approximately 65 employees across 4 continents, including North America, Asia and Africa. Key team members include Chief Executive Officer: J. M., Chairman: S. R. and Director Finance: K. A. Explore Cambridge Technologies's employee directory with LeadIQ.

What industry does Cambridge Technologies belong to?

Minus sign iconPlus sign icon
Cambridge Technologies operates in the Biotechnology Research industry.

What technology does Cambridge Technologies use?

Minus sign iconPlus sign icon
Cambridge Technologies's tech stack includes Google Ads, HubSpot Analytics, Simpli.fi, Microsoft 365, Microsoft Dynamics, ADP, Google Cloud and KnowBe4.

What is Cambridge Technologies's email format?

Minus sign iconPlus sign icon
Cambridge Technologies's email format typically follows the pattern of FLast@cambridgetechnologies.com. Find more Cambridge Technologies email formats with LeadIQ.

How much funding has Cambridge Technologies raised to date?

Minus sign iconPlus sign icon
As of August 2026, Cambridge Technologies has raised $3.5M in funding. The last funding round occurred on Jan 12, 2018 for $3.5M.

When was Cambridge Technologies founded?

Minus sign iconPlus sign icon
Cambridge Technologies was founded in 2015.
Cambridge Technologies logo

Cambridge Technologies

Biotechnology ResearchMinnesota, United States51-200 Employees

Cambridge Technologies is an independent, owner-operated biotechnology firm that develops and produces customized vaccines for veterinary use, working with veterinarians and livestock producers to address emerging animal health problems. The company manages the full vaccine development cycle in-house, leveraging diagnostic and manufacturing capabilities to identify appropriate isolates and translate them into vaccines. 

Production takes place at a USDA-licensed facility in Worthington, Minnesota, a 37,000-square-foot site with a modern fermentation suite. Vaccines are customized to customer needs through tailored formulations and labeling options. In April 2024 Cambridge Technologies announced a partnership with Merck Animal Health USA to provide autogenous poultry vaccines in the United States.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $3.5M

    Cambridge Technologies has raised a total of $3.5M of funding over 1 rounds. Their latest funding round was raised on Jan 12, 2018 in the amount of $3.5M as a Seed.

  • $25M - $50M

    Cambridge Technologies's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.